• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • ID: 2888534
  • May 2014
  • Region: Global
  • 117 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Biomet, Inc.
  • Celanese Corporation
  • Ceradyne, Inc.
  • Collagen Matrix, Inc.
  • Corbion Purac
  • Evonik Industries AG
  • MORE

'Biomaterials Market for Implantable Devices (Material Type - Metals, Polymers, Ceramics and Natural, Applications - Cardiology, Orthopedics, Dental, Ophthalmology and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

The biomaterials market has been extensively analyzed on the basis of material types, their use in various healthcare applications, success rate and geographical reach. Material type segment includes metals, polymers, ceramics and biomaterials derived from natural origin. Each material type is further segmented into various healthcare applications namely, cardiology, orthopedics, dental, ophthalmology and others which include urology, neurology and gasteroenterology. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia and Rest of the World (RoW).

Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biomet, Inc.
  • Celanese Corporation
  • Ceradyne, Inc.
  • Collagen Matrix, Inc.
  • Corbion Purac
  • Evonik Industries AG
  • MORE

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.4 List of Abbreviations
1.5 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Biomaterials Market for Implantable Devices
2.2 Global Biomaterials Market for Implantable Devices, Market Revenue, 2012 (USD Million)
2.3 Comparative Analysis: Global Biomaterials Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 Global Biomaterials Market for Implantable Devices, Market Overview
3.1 Introduction
3.1.1 Definition
3.1.2 Selection of biomaterials
3.2 Biomaterials Access Assurance Act
3.2.1 Regulatory Environment for Use of Biomaterials in Implantable Devices
3.3 Market Drivers
3.3.1 Better outcomes increasing adoption medical implant procedures
3.3.2 Increasing need of medical implants boosts the biomaterial market
3.4 Restraints
3.4.1 Post implantation infections and implant product recalls hindering the market growth
3.4.2 Unsure liability protection offered through biomaterials access assurance act (BAAA) 1998 restrains market growth
3.5 Opportunities
3.5.1 Nanomaterials and tissue engineering will revolutionize the biomaterials market
3.6 Porter's Five Force Analysis for the Global Biomaterials Market for Implantable Devices
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat of New Substitutes
3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis for the Global Biomaterials Market for Implantable Devices, by Geography
3.8 Competitive Landscape
3.8.1 Current Market Scenario

Chapter 4 Global Biomaterials Market for Implantable Devices, by Material type
4.1 Introduction
4.1.1 Examples of Biomaterials
4.1.2 Global Biomaterials Market Revenue, by Material Type, 2011 - 2019 (USD Million)
4.2 Comparative Analysis: Global Biomaterials Market, by Material Type, 2012 & 2019 (Value %)
4.3 Metals
4.3.1 Global Metals Market Revenue, by Application, 2011 - 2019 (USD Million)
4.3.1.1 Metal Biomaterials: Advantages and Disadvantages
4.3.2 Cardiology
4.3.2.1 Global Metal Market, by Cardiology Application, Market Revenue, 2011 - 2019 (USD Million)
4.3.3 Orthopedics
4.3.3.1 Global Metal Market, by Orthopedic Application, Market Revenue, 2011 - 2019 (USD Million)
4.3.4 Ophthalmology
4.3.4.1 Global Metals Market Revenue, by Ophthalmology Application, 2011 - 2019 (USD Million)
4.3.5 Dental
4.3.5.1 Global Metal Market, by Dental Application, Market Revenue, 2011 - 2019 (USD Million)
4.3.6 Others
4.3.6.1 Global Metals Market, by Other Applications, Market Revenue, 2011 - 2019 (USD Million)
4.4 Polymers
4.4.1 Global Polymers Market Revenue, by Application, 2011 - 2019 (USD Million)
4.4.1.1 Polymer Biomaterials: Advantages and Disadvantages
4.4.2 Cardiology
4.4.2.1 Global Polymers Market Revenue, by Cardiology Application, 2011 - 2019 (USD Million)
4.4.3 Orthopedics
4.4.3.1 Global Polymers Market Revenue, by Orthopedic Application, 2011 - 2019 (USD Million)
4.4.4 Ophthalmology
4.4.4.1 Global Polymers Market Revenue, by Ophthalmology Application, 2011 - 2019 (USD Million)
4.4.5 Dental
4.4.5.1 Global Polymers Market Revenue, by Dental Application, 2011 - 2019 (USD Million)
4.4.6 Others
4.4.6.1 Global Polymers Market Revenue, by Other Applications, 2011 - 2019 (USD Million)
4.5 Ceramics
4.5.1 Global Ceramics Market Revenue, by Application, 2011 - 2019 (USD Million)
4.5.1.1 Ceramic Biomaterials: Advantages and Disadvantages
4.5.2 Cardiology
4.5.2.1 Global Ceramics Market Revenue, by Cardiology Application, 2011 - 2019 (USD Million)
4.5.3 Orthopedics
4.5.3.1 Global Ceramics Market Revenue, by Orthopedic Application, 2011 - 2019 (USD Million)
4.5.4 Dental
4.5.4.1 Global Ceramics Market Revenue, by Dental Application, 2011 - 2019 (USD Million)
4.5.5 Ophthalmology
4.5.5.1 Global Ceramics Market Revenue, by Ophthalmology Application, 2011 - 2019 (USD Million)
4.6 Natural Biomaterials (Human origin, animal origin, natural polymers)
4.6.1 Global Natural Biomaterials Market Revenue, by Application, 2011 - 2019 (USD Million)
4.6.2 Cardiology
4.6.2.1 Global Natural Biomaterials Market Revenue, by Cardiology Application, 2011 - 2019 (USD Million)
4.6.3 Orthopedics
4.6.3.1 Global Natural Biomaterials Market Revenue, by Orthopedic Application, 2011 - 2019 (USD Million)
4.6.4 Dental
4.6.4.1 Global Natural Biomaterials Market Revenue, by Dental Application, 2011 - 2019 (USD Million)
4.6.5 Ophthalmology
4.6.5.1 Global Natural Biomaterials Market Revenue, by Ophthalmology Application, 2011 - 2019 (USD Million)
4.6.6 Others
4.6.6.1 Global Natural Biomaterials Market Revenue, by Other Applications, 2011 - 2019 (USD Million)

Chapter 5 Global Biomaterials Market for Implantable Devices, by Geography
5.1 Introduction
5.1.1 Global Biomaterials Market for Implantable Devices, Market Revenue, by Geography, 2011 - 2019 (USD Million)
5.2 North America
5.2.1 North America Biomaterials Market Revenue, 2011 - 2019 (USD Million)
5.2.2 North America Biomaterials Market for Implantable Devices, Market Revenue, by Application, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Biomaterials Market Revenue, 2011 - 2019 (USD Million)
5.3.2 Europe Biomaterials Market for Implantable Devices, Market Revenue, by Application, 2011 - 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Biomaterials Market for Implantable Devices, Market Revenue, by Application, 2011 - 2019 (USD Million)
5.4.2 Asia-Pacific Biomaterials Market Revenue, 2011 - 2019 (USD Million)
5.5 Rest of the World
5.5.1 Rest of the World Biomaterials Market Revenue, 2011 - 2019 (USD Million)
5.5.2 Rest of the World Biomaterials Market for Implantable Devices, Market Revenue, by Applications, 2011 - 2019 (USD Million)

Chapter 6 Recommendations
6.1 Investing in R&D of antimicrobial coatings to reap big pay-offs in future
6.2 Capital investment in emerging markets to sustain in the global market

Chapter 7 Company Profiles
7.1 AdvanSource Biomaterials Corporation
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategy
7.1.5 Recent Developments
7.2 Biomet, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 Celanese Corporation
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 Ceradyne, Inc.
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Collagen Matrix, Inc.
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Corbion Purac
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 DuPont (E. I. DU PONT DE NEMOURS AND COMPANY)
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Evonik Industries AG
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.10 Invibio, Inc.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments
7.11 Orthofix Holdings, Inc.
7.11.1 Business Overview
7.11.2 Financial Overview
7.11.3 Products Portfolio
7.11.4 Business Strategies
7.11.5 Recent Developments
7.12 Royal DSM
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Products Portfolio
7.12.4 Business Strategies
7.12.5 Recent Developments
7.13 Ulbrich Stainless Steels & Special Metals, Inc.
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Product Portfolio
7.13.4 Business Strategies
7.13.5 Recent Developments

List of Figures

FIG. 1 Global Biomaterials Market for Implantable Devices, Market Segmentation
FIG. 2 Global Biomaterials Market for Implantable Devices, Market Revenue, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Biomaterials Market, by Geography, 2012 & 2019 (Value %)
FIG. 4 Global Biomaterials Market :Criteria for selection of biomaterials
FIG. 5 Life expectancy data for selected countries in 1990, 2000 and 2012 (years)
FIG. 6 Porter's Five Forces Analysis: Global Biomaterials Market for Implantable Devices
FIG. 7 Market Attractiveness Analysis: Global Biomaterials Market for Implantable Devices, by Geography
FIG. 8 Global Biomaterials Market : Examples of Biomaterials
FIG. 9 Comparative Analysis: Global Biomaterials Market, by Material Type, 2012 & 2019E (Value %)
FIG. 10 Metal Biomaterials: Advantages and Disadvantages
FIG. 11 Global Metal Market, by Cardiology Application, Market Revenue, 2011 - 2019 (USD Million)
FIG. 12 Global Metal Market Revenue, by Orthopedic Application, 2011 - 2019 (USD Million)
FIG. 13 Global Metal Market, by Ophthalmology Application, Market Revenue, 2011 - 2019 (USD Million)
FIG. 14 Global Metal Market, by Dental Application, Market Revenue, 2011 - 2019 (USD Million)
FIG. 15 Global Metals Market, by Ophthalmology Application, Market Revenue, 2011 - 2019 (USD Million)
FIG. 16 Polymeric Biomaterials: Advantages and Disadvantages
FIG. 17 Global Polymers Market Revenue, by Cardiology Application, 2011 - 2019 (USD Million)
FIG. 18 Global Polymers Market Revenue, by Orthopedic Application, 2011 - 2019 (USD Million)
FIG. 19 Global Polymers Market Revenue, by Ophthalmology Application, 2011 - 2019 (USD Million)
FIG. 20 Global Polymers Market Revenue, by Dental Application, 2011 - 2019 (USD Million)
FIG. 21 Global Polymers Market Revenue, by Other Applications, 2011 - 2019 (USD Million)
FIG. 22 Ceramic Biomaterials: Advantages and Disadvantages
FIG. 23 Global Ceramics Market Revenue, by Cardiology Application, 2011 - 2019 (USD Million)
FIG. 24 Global Ceramics Market Revenue, by Orthopedic Application, 2011 - 2019 (USD Million)
FIG. 25 Global Ceramics Market Revenue, by Dental Application, 2011 - 2019 (USD Million)
FIG. 26 Global Ceramics Market Revenue, by Ophthalmology Application, 2011 - 2019 (USD Million)
FIG. 27 Global Natural Biomaterials Market Revenue, by Cardiology Application, 2011 - 2019 (USD Million)
FIG. 28 Global Natural Biomaterials Market Revenue, by Orthopedic Application, 2011 - 2019 (USD Million)
FIG. 29 Global Natural Biomaterials Market Revenue, by Dental Application, 2011 - 2019 (USD Million)
FIG. 30 Global Natural Biomaterials Market Revenue, by Ophthalmology Application, 2011 - 2019 (USD Million)
FIG. 31 Global Natural Biomaterials Market Revenue, by Other Applications, 2011 - 2019 (USD Million)
FIG. 32 North America Biomaterials Market Revenue, 2011 - 2019 (USD Million)
FIG. 33 Europe Biomaterials Market Revenue, 2011 - 2019 (USD Million)
FIG. 34 Asia-Pacific Biomaterials Market Revenue, 2011 - 2019 (USD Million)
FIG. 35 Rest of the World Biomaterials Market Revenue, 2011 - 2019 (USD Million)
FIG. 36 AdvanSource Biomaterials Corporation: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 37 Biomet, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 38 Celanese Corporation: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 39 Corbion Purac: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 40 DuPont, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 41 Evonik Industries AG: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 42 Orthofix Holdings, Inc., Annual Revenue: 2010-2012 (USD Million)
FIG. 43 Royal DSM : Annual Revenue, 2010 - 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Biomaterials Market for Implantable Devices
TABLE 3 Competitive Landscape: Global Biomaterials Market for Implantable Devices
TABLE 4 Global Biomaterials Market Revenue, by Material Type, 2011 - 2019 (USD Million)
TABLE 5 Global Metals Market Revenue, by Application, 2011 - 2019 (USD Million)
TABLE 6 Global Polymers Market Revenue, by Application, 2011 - 2019 (USD Million)
TABLE 7 Global Ceramics Market Revenue, by Application, 2011 - 2019 (USD Million)
TABLE 8 Global Natural Biomaterials Market Revenue, by Application, 2011 - 2019 (USD Million)
TABLE 9 Other Applications of Natural Biomaterials
TABLE 10 Global Biomaterials Market for Implantable Devices, Market Revenue, by Geography, 2011 - 2019 (USD Million)
TABLE 11 North America Biomaterials Market for Implantable Devices, Market Revenue,by Applications, 2011 - 2019 (USD Million)
TABLE 12 Number of Joint Replacement Procedures in England, Wales and Northern Ireland
TABLE 13 Europe Biomaterials Market for Implantable Devices, Market Revenue,by Applications, 2011 - 2019 (USD Million)
TABLE 14 Asia-Pacific Biomaterials Market for Implantable Devices, Market Revenue,by Applications, 2011 - 2019 (USD Million)
TABLE 15 Rest of the World Biomaterials Market for Implantable Devices, Market Revenue, by Applications, 2011 - 2019 (USD Million)

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biomet, Inc.
  • Celanese Corporation
  • Ceradyne, Inc.
  • Collagen Matrix, Inc.
  • Corbion Purac
  • Evonik Industries AG
  • MORE

Biomaterials are used in medical implantable devices which directly interact with the biological systems. Heart valves, artificial hip joints, dental implants and intraocular lenses are some of the most widely adopted implants to treat critical medical conditions. The high success rates of medical implants have led to greater demand of biomaterials for manufacturing high quality devices. Rising prevalence of osteoarthritis, rheumatoid arthritis and sports injuries are driving the demand for orthopedic implants which in turn increases the demand for biomaterials. In addition, year-on-year rise in cardiac stents implants and non-vascular stents is also driving the market across the globe. The global biomaterials market was valued at USD 25,277.8 million in 2012 and is expected to reach USD 33,600 million in 2019, growing at a CAGR of 4.1% during the forecast period 2013 to 2019.

The biomaterials market comprises of material types such as metals, polymers, ceramics and materials derived from natural resources. Metals constituted the largest segment in the overall biomaterials market with a revenue share of more than 50% in the global biomaterials market. Major metals used in medical applications are alloys of titanium, nickel, chromium, nanosilver, stainless steel and aluminum. However, during the forecast period 2013 to 2019, polymers are expected to register fastest growth amongst all segments mainly because of increasing applications of these biomaterials and several advantages over metals which include flexibility, elasticity, bioinertness, biocompatibility, and longevity. The usage of polymers such as polytetrafluoroethylene (PTFE) and polyurethanes has become popular for synthetic vascular grafts, while the mainstream usage of polymers in ophthalmology is expected to increase with rising incidences of ophthalmic disorders and constant demand from aging population.

In 2012, North America held the majority share in the global biomaterials market followed by Europe. These two regions together account for more than 80% of global biomaterials market and are expected to retain their position throughout the forecast period 2013 to 2019. Large number of medical implant procedures carried out in the developed nations such as the U.S., Canada, U.K., Germany, and France has been the major driver for growth of biomaterials market in North America and Europe. In Asia-Pacific region, Japan, South Korea, Australia and New Zealand are the major markets for biomaterial due to the increasing adoption of medical implant procedures in these countries. Additionally, these countries demand advanced biomaterials compared to other small developing countries in the region. However, biomaterial manufacturers view emerging countries such as China, India and Malaysia as lucrative markets due to underserved medical implants market, large patient base and high population in these nations. In Rest of the World (RoW), countries such as Brazil and South Africa are the prominent markets for biomaterials where noteworthy growth is expected in the coming years.

Biomet, Inc., AdvanSource Biomaterials Corporation, Celanese Corporation, Ceradyne, Inc., Collagen Matrix, Inc., DuPont, Royal DSM, Evonik Industries AG, Corbion Purac, and Invibio, Inc. are some of the major companies operating in the global biomaterials market for implantable devices.

Note: Product cover images may vary from those shown

- AdvanSource Biomaterials Corporation
- Biomet, Inc.
- Celanese Corporation
- Ceradyne, Inc.
- Collagen Matrix, Inc.
- Corbion Purac
- DuPont (E. I. DU PONT DE NEMOURS AND COMPANY)
- Evonik Industries AG
- Invibio, Inc.
- Orthofix Holdings, Inc.
- Royal DSM
- Ulbrich Stainless Steels & Special Metals, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos